Mark Dias

Yale University — United States

Neuroscience · Life Sciences

10h-index505citations19works7.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(6), Medical Imaging Techniques and Applications(6), Parkinson's Disease Mechanisms and Treatments(5), Neurological disorders and treatments(5), Advanced MRI Techniques and Applications(4)

Publications19 total

Carotid Artery Image-Derived Blood Time–Activity Curves on the NeuroEXPLORER: Initial Multitracer Validation Against Arterial Sampling
Journal of Nuclear Medicine·2025· 3 cited
Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual‐Tracer Positron Emission Tomography Imaging Study
Movement Disorders·2025
PET Imaging of Synaptic Density Loss in Patients with Multiple Sclerosis
2025· 1 citedOpen Access
Author Correction: Synaptic loss and its association with symptom severity in Parkinson’s disease
npj Parkinson s Disease·2024· 2 citedOpen Access
Synaptic loss and its association with symptom severity in Parkinson’s disease
npj Parkinson s Disease·2024· 29 citedOpen Access
First-in-Human Study of<sup>18</sup>F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding
Journal of Nuclear Medicine·2024· 12 citedOpen Access
Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [18F]FE-PE2I PET: independent validation with new insights
Brain Communications·2024· 6 citedOpen Access
The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J
European Journal of Nuclear Medicine and Molecular Imaging·2023· 22 citedOpen Access
Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults
Journal of Psychopharmacology·2022· 10 citedOpen Access
Evaluation of [18F]SynVesT-2 for imaging SV2A in the human brain: kinetics, test-retest reproducibility, and binding specificity
2021· 1 cited
Assessment of population-based input functions for Patlak imaging of whole body dynamic 18F-FDG PET
EJNMMI Physics·2020· 91 citedOpen Access
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [<sup>11</sup>C]UCB‐J positron emission tomography study
Epilepsia·2020· 74 cited
First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals
2020· 9 cited
Issue Information
Annals of Neurology·2020· 1 citedOpen Access
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
Annals of Neurology·2020· 175 citedOpen Access
Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers
Neuropsychopharmacology·2019· 33 citedOpen Access
Age and sex effects on synaptic density in healthy humans as assessed with SV2A PET
2018· 10 cited
Vasoactive properties of calcitonin gene-related peptide in human skin.
PubMed·2011· 5 cited
The inhibitory effects of local anaesthetics on the vascular flare responses to bradykinin and substance P in human skin*
Anaesthesia·2008· 21 citedOpen Access

Frequent Co-authors

Richard E. Carson(17), David Matuskey(14), Mika Naganawa(14), Nabeel Nabulsi(13), Shannan Henry(11), Takuya Toyonaga(10), Sjoerd J. Finnema(9), Jean‐Dominique Gallezot(9), Jim Ropchan(8), Yiyun Huang(8), Sule Tinaz(6), Brian Pittman(6), Robert A. Comley(6), Ansel T. Hillmer(5), Songye Li(4), Praveen Honhar(4), Yanghong Yang(4), Irina Esterlis(4), Adam P. Mecca(4), Soheila Najafzadeh(4)